Advancing Lung Cancer Care through Genomic Testing: Industry Report (2021-2031)

According to BIS Research, The Lung Cancer Genomic Testing Medicine Market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.

Read detailed insights at: https://bit.ly/41A0f7O

 

bit.ly

Lung Cancer Genomic Testing Market - A Global and Regional Analysis: Focus on Product, Technology, Panel Type, Sample Type, and End User - Analysis and Forecast, 2021-2031

The lung cancer genomic testing medicine market is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97%. BIS Research provides deep market insight, industry analysis, trends & forecast to 2026 that will help your business to grow.